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OBJECTIVE—Obesity is characterized by an overgrowth of
adipose tissue that leads to the formation of hypoxic areas within
this tissue. We investigated whether this phenomenon could be
responsible for insulin resistance by studying the effect of
hypoxia on the insulin signaling pathway in adipocytes.
RESEARCH DESIGN AND METHODS—The hypoxic signal-
ing pathway was modulated in adipocytes from human and
murine origins through incubation under hypoxic conditions (1%
O2) or modulation of hypoxia-inducible factor (HIF) expression.
Insulin signaling was monitored through the phosphorylation
state of several key partners of the pathway and glucose
transport.
RESULTS—In both human and murine adipocytes, hypoxia
inhibits insulin signaling as revealed by a decrease in the
phosphorylation of insulin receptor. In 3T3-L1 adipocytes, this
inhibition of insulin receptor phosphorylation is followed by a
decrease in the phosphorylation state of protein kinase B and
AS160, as well as an inhibition of glucose transport in response to
insulin. These processes were reversible under normoxic condi-
tions. The mechanism of inhibition seems independent of protein
tyrosine phosphatase activities. Overexpression of HIF-1 or -2 or
activation of HIF transcription factor with CoCl2 mimicked the
effect of hypoxia on insulin signaling, whereas downregulation of
HIF-1 and -2 by small interfering RNA inhibited it.
CONCLUSIONS—We have demonstrated that hypoxia creates a
state of insulin resistance in adipocytes that is dependent upon
HIF transcription factor expression. Hypoxia could be envi-
sioned as a new mechanism that participates in insulin resistance
in adipose tissue of obese patients. Diabetes 58:95–103, 2009
O
besity results from an imbalance between en-
ergy intake and energy expenditure. Abdominal
obesity and adipose tissue dysfunction are ma-
jor risk factors for chronic diseases, such as
insulin resistance, type 2 diabetes, and cardiovascular
diseases. Insulin resistance is associated with alterations
in glucose and lipid homeostasis. At the molecular level,
insulin resistance is triggered by a dysregulation of the
insulin signaling cascade. Insulin stimulates the tyrosine
kinase activity of its receptor, leading to tyrosine phos-
phorylation of its substrates, such as insulin receptor
substrate (IRS)-1 and -2 or Shc. They are upstream of two
major signaling pathways: the phosphatidylinositol 3-ki-
nase/protein kinase B (PKB) pathway, responsible for
most of the metabolic actions of insulin, and the Ras–
extracellular signal–related kinase pathway, which regu-
lates gene expression (1).
During the genesis of obesity, adipose tissue is one of
the ﬁrst tissues affected by insulin resistance. This phe-
nomenon is closely associated with the development of a
proinﬂammatory state within the adipose tissue. In addi-
tion to this proinﬂammatory state, obesity is associated
with the formation of hypoxic areas within the tissue. This
has been demonstrated in obese mice (ob/ob and dietary
induced obesity) using various methods, such as immuno-
histochemistry with pimonidazole, use of O2 sensor
probes, and lactate detection (2–4). Hypoxia, a deﬁciency
in O2, is a major stimulus affecting a number of biological
functions, such as angiogenesis, cell proliferation, apopto-
sis, and inﬂammation, and it switches cell metabolism from
aerobic respiration to anaerobic glycolysis (5–7). Hypoxia
mediates its effect through the activation of hypoxia-induc-
ible factor (HIF), a basic helix-loop-helix transcription factor
composed of two subunits, HIF- and -. Although HIF- is
constitutively expressed, HIF- protein level is regulated. In
the presence of O2, HIF- is subjected to proline hydroxyla-
tion, leading to degradation by the proteasome. Hypoxia
inactivates prolyl-hydroxylases, leading to HIF- accumula-
tion and formation of a functional heterodimeric transcrip-
tion factor. Two subunits, HIF-1and -2, show similarities
in structure and regulation, but they regulate distinct sets of
genes and are not redundant (5,7,8). HIF-1 and -2 expres-
sion are also regulated by O2-independent mechanisms be-
cause growth factors and cytokines stimulate HIF-1 and -2
protein synthesis via phosphatidylinositol 3-kinase or extra-
cellular signal–related kinase pathways (9–12). Because hyp-
oxia produces profound changes in cell metabolism, we
investigated its effect on insulin signaling.
In the current study, we demonstrated that hypoxia
creates an insulin-resistant state in adipocytes by inhibit-
ing phosphorylation of the insulin receptor tyrosine, lead-
ing to a decrease in glucose transport. This phenomenon
could contribute to the development of insulin resistance
within adipose tissue.
RESEARCH DESIGN AND METHODS
Insulin was obtained from Lilly (Paris, France). Antibodies to HIF-1 (clone
H167) and HIF-2 were purchased from Novus Biologicals (Littleton, CO).
Antibodies to GLUT1 and HIF-2 were obtained from Abcam (Paris, France).
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PKB, and GLUT-4 were purchased from Cell Signaling Technology (Beverly,
MA). Antibody to phospho-S6 kinase 1, insulin receptor-, and small interfer-
ing RNA (siRNA; control, HIF-1, and -2) were purchased from Santa Cruz
Biotechnology (Tebu, France). Polyclonal insulin receptor substrate (IRS)-1
and -2 antibodies used in immunoprecipitation experiments were raised
against a peptide corresponding to the last 14 amino acids of IRS-1 and a
peptide corresponding to the last 16 amino acids of IRS-2 (Eurogentec,
Seraing, Belgium). Polyclonal antibody directed against phospho-Ser632 IRS-1
has been described previously (13). Monoclonal anti–IRS-1 antibody used in
immunoblotting experiments was purchased from BD Biosciences (PharMin-
gen, San Diego, CA). Antibody to tubulin was purchased from Sigma-Aldrich.
Culture media were from Invitrogen.
DNA plasmids. Plasmid enhanced green ﬂuorescent protein–C1-HIF-1–
green ﬂuorescent protein (pEGFP-C1-HIF-1-GFP) has been described previ-
ously (10). pcDNA3-HIF-2 cDNA was obtained from Steve McKnight and
Richard Bruick (University of Texas Southwestern Medical Center) (14).
Cell culture. Human embryonic kidney cells (HEK-293) were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 5% (vol/vol) FCS.
3T3-L1 ﬁbroblasts were grown at 7% CO2 and 37°C in DMEM supplemented
with 10% (vol/vol) calf serum and induced to differentiate as previously
described (15). Human preadipocytes obtained from Biopredic (Rennes,
France) were grown and induced to differentiate as previously described (16).
Transfection. HEK-293 cells were transiently transfected using FuGENE 6
transfection reagent (Roche Diagnostics, Indianapolis, IN), according to the
manufacturer’s instructions. siRNAs were transfected using INTERFERin
siRNA transfection reagent according to the manufacturers instructions
(Polyplus Transfection; Ozyme). Brieﬂy, differentiated 3T3-L1 adipocytes were
trypsinized and seeded in 12-well plates. After 24 h, siRNAs (50 nmol/l)
directed against HIF-1 or -2 were transfected using INTERFERin and used
48 h after transfection.
Hypoxia treatment. For hypoxic incubations, medium was replaced with
DMEM containing 0.5% BSA (wt/vol), and adipocytes were incubated at 37°C
in 95% air and 5% CO2 (normoxic conditions) or placed in a hypoxic chamber
(Billups-Rothenberg, Dell Mar, CA) ﬂushed for 10 min with gas mixture
consisting of 1% O2,5 %C O 2, and 94% N2 (hypoxic conditions). Cells were
incubated for 16 h at 37°C. After hypoxic incubation, the chambers were
opened in an anaerobic glove box (ﬂushed with N2) to avoid reoxygenation.
Cells were stimulated with ligands, and cell lysates were prepared. Absence of
cytotoxicity was assessed by measuring lactate deshydrogenase activity
according the manufacturer’s instructions (Roche). For short-term hypoxia
experiments, media were ﬂushed with N2 within the anaerobic glove box to
remove O2 from the medium prior to hypoxic incubation.
Western blot analysis. Adipocytes were resuspended in lysis buffer (50
mmol/l HEPES [pH 7.4], 150 mmol/l NaCl, 10 mmol/l EDTA, 10 mmol/l
Na4P2O7, 100 mmol/l NaF, 2 mmol/l vanadate, protease inhibitor cocktail
[Complete; Roche], and 1% [vol/vol] Triton X-100) and immediately frozen in
liquid nitrogen. Lysates were centrifuged (14,000 rpm) for 10 min at 4°C, and
the protein concentration was determined using BCA protein assay reagent
(Pierce). Cell lysates were either directly analyzed by Western blot or were
subjected to immunoprecipitation. Immunoblottings were performed as pre-
viously described (10) and were revealed using a Fujiﬁlm LAS-3000 imaging
system. Quantiﬁcations were realized using MultiGauge software.
Measurement of reactive oxygen species. 3T3-L1 adipocytes were incu-
bated for 30 min with 10 mol/l 2,7-dichlorodihydroﬂuorescein diacetate
(DCFH-DA; Molecular Probes) in PBS. DCFH-DA was removed and adipo-
cytes incubated in normoxia or hypoxia. After washes, adipocytes were
sonicated in water. Fluorescence was determined at 485/520 nm and normal-
ized to protein concentration.
Glucose transport. 3T3-L1 adipocytes were incubated for 16 h in normoxia
or hypoxia and were stimulated with 100 nmol/l insulin for 20 min in normoxia
or hypoxia. Glucose transport was determined by the addition of 2-[
3H]deoxy-
glucose (0.1 mmol/l, 0.5 Ci/ml) as previously described (15).
Glycerol release and interleukin-1 and -6 measurement. Glycerol was
measured in cell culture media using free glycerol reagent (Sigma-Aldrich,
Lyon, France), and interleukin (IL)-1 and -6 were measured in cell culture
media using a RayBio enzyme-linked immunosorbent assay kit (Tebu, France)
according to the manufacturer’s instructions.
Protein tyrosine phosphatase activity. Adipocytes were incubated in
normoxia or hypoxia and were homogenized inside an anaerobic glove box
(17). Insulin stimulation, cell homogenization, and protein tyrosine phospha-
tase (PTPase) assay were performed in anaerobic conditions to avoid any air
oxidation. Cell were lysed in PTPase lysis buffer (150 mmol/l NaCl, 5 mmol/l
EDTA, 5 mmol/l EGTA, and 50 mmol/l HEPES, pH 7.5, containing protease
inhibitor cocktail [Complete; Roche] and 1% [vol/vol] Triton X-100) followed
by centrifugation at 14,000 rpm for 15 min. PTPase activity was determined at
30°C for 30 min in a reaction buffer containing 20 mmol/l para-nitrophenyl
phosphate in 50 mmol/l Tris (pH 7.5), 50 mmol/l NaCl, and 3 mmol/l
dithiothreitol, and the absorption was determined at 410 nm (18). Positive
control was performed using puriﬁed calf intestinal phosphatase.
Statistical analysis. Statistical differences between groups were analyzed by
Student’s t test and were considered signiﬁcant at P  0.05.
RESULTS
Hypoxia inhibits the insulin signaling pathway in
human adipocytes and 3T3-L1 adipocytes. Because
obesity is associated with the formation of hypoxic areas
within the adipose tissue, we investigated the effect of
hypoxia on the insulin signaling pathway in adipocytes.
Murine 3T3-L1 adipocytes were incubated in normoxia or
hypoxia (1%) for 16 h before being stimulated with insulin
for 5 min. The condition of 1% O2 is similar to that found
in the adipose tissue of obese mice (15.2 mmHg, 1–2% O2)
(2,3). Hypoxia induced an increase in HIF-1 and -2
protein levels in 3T3-L1 adipocytes (Fig. 1A). In parallel,
hypoxia inhibited the ability of insulin to stimulate the
autophosphorylation of its receptor as well as the phos-
phorylation of PKB (Fig. 1B). 3T3-L1 adipocytes were
incubated for 16 h in normoxia or in hypoxia before being
stimulated with decreasing amounts of insulin (ranging
from 100 to 0.01 nmol/l). The inhibition of insulin-induced
insulin receptor phosphorylation by hypoxia was observed
at maximal and submaximal insulin concentrations. More-
over, hypoxia inhibited S6 kinase (S6K) phosphorylation
in response to insulin (Fig. 1C).
Speciﬁc immunoprecipitation of IRS-1 or -2 revealed
that hypoxia inhibited IRS-1 and -2 tyrosine phosphoryla-
tion (Fig. 1D). Because serine phosphorylation of IRS-1 is
implicated in the inhibition of its tyrosine phosphorylation
and in insulin resistance (19), we investigated the level of
IRS-1 serine phosphorylation. Hypoxia inhibited the phos-
phorylation of Ser632 residue in response to insulin (Fig.
1D). No effect of hypoxia on the phosphorylation on
Ser307 and Ser789 was detected (data not shown). It is to
be noted that hypoxia did not induce cell toxicity, as
measured by lactate deshydrogenase activity, or caspase 3
activity (data not shown). Because general tissue oxygen-
ation is 50 mmHg (7% O2), the ability of 3T3-L1 adipo-
cytes to respond to insulin treatment after incubation in
21%, 7%, or 1% O2 was examined. Adipocytes incubated in
21% or 7% O2 responded similarly to insulin stimulation
(Online Appendix 1, available at http://dx.doi.org/10.2337/
db08-0457).
Hypoxia also inhibited insulin signaling pathway in
human adipocytes (Fig. 1E). Indeed, human adipocytes
were incubated in normoxia (21% O2) or in hypoxia (1%
O2) for 24 h and stimulated with insulin for 5 min. Hypoxia
stimulated HIF-1 and -2 protein expression and inhib-
ited insulin-induced insulin receptor and IRS tyrosine
phosphorylation. In conclusion, in both human and murine
adipocytes, hypoxia inhibited the ability of insulin to
induce the phosphorylation of its receptor as well as IRS-1,
IRS-2, PKB, and S6K.
Inhibition of insulin-induced insulin receptor ty-
rosine phosphorylation by hypoxia is rapid and
reversible. The time course of hypoxia-induced inhibition
of insulin receptor phosphorylation was evaluated by
incubating 3T3-L1 adipocytes in normoxia or hypoxia for
1, 4, 8, and 16 h before being stimulated with insulin for 5
min. As shown in Fig. 2A, the inhibitory effect of hypoxia
on insulin receptor tyrosine phosphorylation was detected
as soon as 1 h. These effects were more pronounced after
8 h of hypoxia. These observations demonstrate that
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signaling pathway.
To determine whether the effect of hypoxia is reversible,
3T3-L1 adipocytes were incubated in hypoxia for 16 h.
Hypoxic adipocytes were stimulated directly after hypoxia
or were reoxygenated for 15 and 45 min before insulin
stimulation (Fig. 2B). Control adipocytes were maintained
in normoxia for 16 h and stimulated with insulin. Hypoxia
impaired the ability of insulin to stimulate insulin receptor
tyrosine phosphorylation as well as PKB and AS160 phos-
phorylation. During reoxygenation, the ability of insulin to
stimulate phosphorylation of insulin receptor and signal-
ing proteins was restored after 45 min.
Hypoxia inhibits glucose transport. PKB and its sub-
strate AS160 play an important role in insulin-induced
GLUT4 translocation and glucose transport. We investi-
gated whether hypoxia inhibited the downstream response
of insulin, such as glucose transport in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated in normoxia or hypoxia
for 16 h or reoxygenated for 1 h. Glucose transport was
determined by the increase in [
3H]deoxyglucose (Fig. 3A).
In normoxic adipocytes, insulin induced a 10-fold increase
in glucose transport. Hypoxia upregulated basal glucose
transport but inhibited insulin-induced glucose transport.
Reoxygenation of adipocytes restored the ability of insulin
to stimulate glucose entry to levels comparable to nor-
moxic adipocytes. In reoxygenated adipocytes, basal glu-
cose transport remained elevated. This increase in basal
glucose uptake probably resulted from increased GLUT1
expression, which was maintained even after1ho f
reoxygenation, without modifying GLUT4 protein levels
(Fig. 3B).
Hypoxia induces reactive oxygen species generation
in 3T3-L1 adipocytes. Insulin resistance has been asso-
ciated with the generation of reactive oxygen species. We
investigated whether hypoxia induced reactive oxygen
species (ROS) production in 3T3-L1 adipocytes. To this
end, we monitored the formation of ROS detected by the
oxidation of the DCFH dye (20). Hypoxia stimulated the
generation of ROS as soon as 1 h, which was maintained
up to 16 h (Fig. 4A). Formation of ROS was in part
inhibited by the antioxidant N-acetyl cysteine.
Hypoxia does not inhibit insulin signaling through
the activation of protein tyrosine phosphatases.
Attenuation of insulin signaling can occur through the
dephosphorylation of the receptor by protein tyrosine
phosphatase (PTPase). PTPase-1B and leukocyte antigen–
related phosphatase have been implicated in insulin recep-
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FIG. 1. Hypoxia inhibited insulin-induced insulin receptor
tyrosine phosphorylation in human and 3T3-L1 adipocytes.
A: 3T3-L1 adipocytes were incubated for 16 h at 37°C in
normoxia (21% O2) or hypoxia (1% O2). Cell lysates were
analyzed by immunoblots with the indicated antibodies. B:
3T3-L1 adipocytes were incubated for 16 h at 37°C in
normoxia (21% O2) or hypoxia (1% O2) before being
stimulated with insulin (100 nmol/l) for 5 min. C: 3T3-L1
adipocytes were incubated for 16 h at 37°C in normoxia
(21% O2) or hypoxia (1% O2) before being stimulated with
decreasing concentrations of insulin ranging from 100 to
0.01 nmol/l. D: Cell lysates were subjected to immunopre-
cipitation using antibodies to IRS-1 or -2 followed by
immunoblots using indicated antibodies. E: Human adipo-
cytes were obtained after differentiation of preadipocytes
and were incubated for 24 h at 37°C in normoxia (21% O2)
or hypoxia (1% O2). After insulin stimulation (100 nmol/l)
for 5 min, cell lysates were analyzed by immunoblots with
indicated antibodies. Representative experiments of at
least three independent experiments performed in dupli-
cate or triplicate are shown. IP, immunoprecipitation; IR,
insulin receptor; pTyr, phosphorylated tyrosine; pS6K,
phospho-S6K 1; pSer632, phospho-Ser632.
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hypoxia modulated total phosphatase activity by measur-
ing the dephosphorylation of para-nitrophenyl phosphate.
Cell homogenization and measurement of phosphatase
activities were performed in anaerobic conditions to avoid
oxidation and their subsequent inhibition. No signiﬁcant
difference in total phosphatase activity was observed in
hypoxia compared with normoxia (Fig. 4B).
To conﬁrm the lack of implication of PTPases in
hypoxia-mediated inhibition of the insulin pathway, we
studied whether vanadate, a potent tyrosine phosphatase
inhibitor, could reverse the effect of hypoxia. Adipocytes
were incubated in normoxia or hypoxia in the absence or
presence of vanadate for 16 h before insulin stimulation
(Fig. 4C). Although vanadate increased the level of protein
tyrosine phosphorylation in normoxia, because of the
inhibition of cellular phosphatases, it did not restore the
ability of insulin to stimulate the tyrosine phosphorylation
of its receptor in hypoxia. Similar results were obtained
with H2O2, which induced oxidation and subsequent inhi-
bition of tyrosine phosphatases (data not shown). These
results suggest that hypoxia did not mediate its action
through the activation of tyrosine phosphatase activities.
Hypoxia stimulates lipolysis and IL-6 secretion. Free
fatty acids and adipokines have been shown to be impli-
cated in the development of insulin resistance. Thus, we
investigated whether these factors could play a role in the
inhibition of the insulin signaling pathway by hypoxia.
First, we measured the release of glycerol and two adipo-
kines, IL-1 and -6, in the conditioned media from nor-
moxic or hypoxic adipocytes. 3T3-L1 adipocytes were
subjected to normoxia or hypoxia for 16 h, conditioned
media were collected, and glycerol (Fig. 5A) and IL-1 and
-6 (Fig. 5B) were measured. Hypoxia induced a release of
glycerol in the media (48 g/ml  2 in hypoxia compared
with 4 g/ml  0.7 in normoxia). Moreover, IL-6 secretion
was increased from 0.1  0.02 ng/ml in normoxia up to
2.1  0.28 ng/ml after 16 h of hypoxia. In contrast, the
IL-1 protein level was not modiﬁed. Shorter incubations
did not allow us to detect IL-6 or -1 expression (data not
shown).
Then, we investigated whether the inhibition of insulin
signaling by hypoxia could be mimicked by conditioned
media. 3T3-L1 adipocytes were incubated under hypoxia
or normoxia for 16 h, and the conditioned medium was
collected and incubated with 3T3-L1 adipocytes for 16 h
before stimulation with insulin (Fig. 5C). The effect of
conditioned media was compared with the effect of hyp-
oxia. As previously shown, hypoxia inhibited insulin-
induced insulin receptor tyrosine phosphorylation and
PKB phosphorylation compared with normoxic condi-
tions. In the presence of conditioned media from hypoxic
adipocytes, we did not observe a signiﬁcant decrease in
the insulin-induced phosphorylation of the insulin recep-
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FIG. 2. The effect of hypoxia on the insulin signaling pathway is rapid and reversible. A: Prior to hypoxic incubation, the medium was ﬂushed with
N2 within an anaerobic glove chamber to remove O2 from the medium. 3T3-L1 adipocytes were incubated in normoxia (21% O2) or hypoxia (1%
O2) for 1, 4, 8, and 16 h at 37°C. Adipocytes were stimulated with insulin (100 nmol/l) for 5 min, and cell lysates were analyzed by immunoblots
with antiphosphotyrosine and insulin receptor antibodies. Quantiﬁcation of insulin receptor tyrosine phosphorylation compared with the amount
of insulin receptor of four to ﬁve independent experiments performed in duplicate is shown. B: 3T3-L1 adipocytes were incubated in normoxia
or hypoxia (1% O2) for 16 h before being reoxygenated for 15 and 45 min at 37°C. Normoxic, hypoxic, and reoxygenated adipocytes were
stimulated with insulin (100 nmol/l) for 5 min. Cell lysates were analyzed by immunoblots with indicated antibodies. A representative experiment
of three independent experiments performed in duplicate is shown. Ins, insulin; IR, insulin receptor; pAS160, phospho-AS160; pThr308 PKB,
phospho-Thr308 PKB; pTyr, phosphorylated tyrosine; Reox, reoxygenation. *P < 0.05; ***P < 0.001.
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of adipokines is dysregulated during hypoxia, they cannot
be responsible for the inhibition of insulin signaling in-
duced by hypoxia.
Effect of hypoxia on inhibition of the insulin signaling
pathway is mimicked by CoCl2 and HIF- expression.
Hypoxia allows the stabilization of HIF- subunits, leading
to the activation of the HIF transcription factor. CoCl2 is a
hypoxia-mimicking agent that promotes HIF- stabiliza-
tion, HIF activation, and expression of hypoxia-induced
genes (22). We investigated whether CoCl2 could mimic
the effect of hypoxia on the insulin signaling pathway.
3T3-L1 adipocytes were treated with CoCl2 for 16 h
followed by insulin stimulation. As shown in Fig. 6A, CoCl2
induced HIF-2 expression. Concomitantly, CoCl2 de-
creased the ability of insulin to stimulate insulin receptor
and IRS tyrosine phosphorylation without affecting their
respective protein levels. In parallel, CoCl2 inhibited the
phosphorylation of S6K in response to insulin.
Similar results were obtained when the expression of
HIF-1 and -2 was induced by transfection of HIF-1 and
-2 into HEK-293 cells before insulin stimulation. Ectopic
expression of HIF-1 or -2 subunits led to a decrease in
the ability of insulin to stimulate its receptor autophos-
phorylation compared with control cells (Fig. 6B). To-
gether, these results show that enhanced HIF expression
inhibits insulin signaling.
Inhibition of HIF activity restores insulin stimula-
tion of the insulin receptor. Because we showed that
HIF expression was sufﬁcient to induce insulin resistance,
we investigated whether expression of these proteins was
necessary for the inhibition of insulin signaling. HIF-1 or
-2 expression was inhibited by siRNA transfection in
3T3-L1 adipocytes (Fig. 7). The siRNAs were able to partly
inhibit (57  3%) HIF-1 and -2 expression under hyp-
oxia. This was accompanied by a partial restoration of the
ability of insulin to stimulate the tyrosine phosphorylation
of its receptor.
The use of echinomycin, an inhibitor that has been
characterized to inhibit HIF activity without modulating
HIF- subunit protein levels (23), led also to partial
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FIG. 4. Hypoxia increased ROS generation but did not activate protein tyrosine phosphatases. A: 3T3-L1 adipocytes were incubated with
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means  SE of three independent experiments performed in triplicate. C: 3T3-L1 adipocytes were incubated in normoxia or hypoxia for 16 h in
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the insulin receptor in hypoxia (data not shown). To-
gether, these results show that hypoxia inhibited insulin
receptor and IRS tyrosine phosphorylation through mech-
anisms that are dependent of HIF transcription factors.
DISCUSSION
Obesity is associated with insulin resistance and type 2
diabetes. Massive development of the adipose tissue leads
to the formation of hypoxic areas. As adipose tissue
expands, some adipocytes become too distant from the
vasculature to be correctly oxygenated. Indeed, develop-
ment of hypoxia in the adipose tissue has been described
in several genetic models of obesity in rodents. Partial
pressure of O2 in the adipose tissue decreases from 47.9
mmHg in lean mice to 15.2 in ob/ob mice (2,3). In humans,
the existence of hypoxia in the adipose tissue of obese
patients is supported by the observation that although
obese patients have more adipose tissue than lean pa-
tients, the cardiac output and blood ﬂow directed to
adipose tissue are not increased during obesity (24).
Moreover, HIF-1 and HIF-1 target genes are overexpressed
in the adipose tissue of obese individuals and decrease
after weight loss (25). Finally, obesity is associated with
hypertrophic adipocytes in which size prohibits a correct
diffusion of O2 within the tissue.
In the current study, we propose that this hypoxic status
within the adipose tissue could contribute to the develop-
ment of insulin resistance directly through the inhibition
of the insulin signaling pathway in adipocytes. In rodent
adipocytes, hypoxia induces a rapid and robust inhibition
of insulin signaling, as shown by a 50% inhibition of insulin
receptor autophosphorylation and nearly complete inhibi-
tion of insulin-stimulated glucose transport. Because hyp-
oxia affects the earliest intracellular step of insulin
signaling, i.e., insulin receptor autophosphorylation, all
subsequent steps, such as IRS and PKB phosphorylation
and glucose transport, were affected. The mechanisms
used by hypoxia to inhibit the insulin signaling pathway is
not fully understood. Using experiments of gain and loss
of function, we have shown that the inhibition of insulin
signaling by hypoxia is dependent upon HIF-1 and -2
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nmol/l insulin for 5 min. Cell lysates were analyzed with indicated antibodies. A representative experiment of four independent experiments
performed in duplicate is shown. D: Quantiﬁcation of tyrosine phosphorylation of insulin receptor compared with insulin receptor protein of four
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implicated in a broad range of cellular responses. HIF-1
and -2 are activated at different O2 concentrations,
HIF-1 being more sensitive to O2 concentration. Although
HIF-1 and -2 share common target genes, some speciﬁcity
in gene expression has been revealed (5,7). Because
downregulation of HIF-1 or -2 counteracts hypoxia-
induced insulin resistance, it is likely that proteins in-
volved are common target genes. These target genes are
predicted to have a short half-life or to be rapidly inhib-
ited. Indeed, hypoxia-induced insulin resistance is rapidly
reversible. Reoxygenation restores insulin response after
45 min, as observed by an increase in insulin-stimulated
insulin receptor phosphorylation and glucose transport.
Interestingly, HIF proteins are not only induced during
hypoxia but have also been reported to be induced by
growth factors and cytokines. Because several of these
circulating molecules have been shown to interact with
insulin signaling, the HIF-mediated inhibition of insulin
signaling described here could not be restricted to hyp-
oxia. Moreover, we cannot exclude that HIF proteins
mediate their effect independently of their action on
transcription.
What could be the molecular mechanisms by which
hypoxia mediates insulin resistance? PTPases, which
could dephosphorylate the insulin receptor, seem not to
be regulated by hypoxia. We show that hypoxia induces
the production of ROS, which have been linked to im-
paired insulin signaling (26), through an increase in serine
phosphorylation of IRS. We have not detected any in-
crease in the phosphorylation status of IRS-1 serine phos-
phorylation, which has been associated with insulin
resistance (Ser307, Ser789, and Ser632). Moreover, phos-
phorylation of these sites has not been reported to affect
insulin receptor kinase activity. Hypoxia decreased IRS-1
serine phosphorylation on Ser632 residue, which is a
target for mammalian target of rapamycin (mTOR) and
S6K (19). Under hypoxia, energy expenditure is decreased,
leading to the inhibition of high–energy-consuming events
such as protein translation, leading to the inhibition of
mTOR and S6K (27). However, one cannot exclude that
ROS could affect insulin receptor tyrosine kinase activity
directly or indirectly. Unfortunately, this is particularly
difﬁcult to investigate because ROS inhibitors by them-
selves directly affect insulin receptor tyrosine kinase ac-
tivity (28) (data not shown).
In adipose tissue, hypoxia dysregulates the expression
of some adipokines and proinﬂammatory cytokines (2–
4,24,29,30), such as leptin, adiponectin, IL-1, and IL-6,
although tumor necrosis factor- expression seems to be
insensitive to hypoxia in human adipocytes (29). These
cytokines are known to be involved in the downregulation
of the insulin signaling pathway and to induce local and
systemic insulin resistance (2,15). Analysis of conditioned
media revealed that IL-6 protein secretion was increased
by hypoxia but at concentrations inferior to that described
to inhibit the insulin signaling pathway in adipocytes (2 vs.
20 ng/ml) (31). Thus, incubation of conditioned media
from hypoxic adipocytes for 16 h did not mimic the effect
of hypoxia on the inhibition of the insulin signaling path-
way. This suggests that hypoxia-induced cytokine produc-
tion by adipocytes is not the mechanism responsible for
the inhibition of insulin signaling that we describe here.
This is consistent with the observation that during hypoxia
and obesity, cytokines are mainly produced by macro-
phages that invade the adipose tissue and not by adipo-
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direct effect of hypoxia on adipocytes.
The role of hypoxia in insulin resistance could be
envisioned as a multistep process. In a ﬁrst and early
series of events, hypoxia induces local insulin resistance
inside the adipose tissue by inhibiting the insulin signaling
pathway. In a second and longer process, hypoxia attracts
macrophages within the adipose tissue, leading to dys-
regulation of adipokine expression (3,32), which will be
involved in the development of local, but also systemic,
insulin resistance. Third, by creating a niche, hypoxia
could increase mesenchymal stem cells’ self-renewal while
inhibiting adipocyte differentiation in restricted parts of
the tissue (6,33). Then, through angiogenesis, hypoxia
could create new vessels that would lead to reoxygenation
of these niches, leading to the development of new adipo-
cytes. As obesity progresses, this mechanism could create
a vicious circle aggravating the syndrome.
In conclusion, we show here that hypoxia inhibits
insulin signaling in adipocytes through HIF proteins. This
mechanism could be involved in the establishment of an
insulin-resistant state during obesity.
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